Don’t Trade in the Dark—Get Your Pre-Market Report Every Day.Join Now
Run a search on a company

Zenith Drugs Ltd

Pharmaceuticals & Biotechnology | Small Cap

Zenith Drugs Ltd Health Insights
Health Score : 4.63Health Score : 4.63

Zenith Drugs Ltd demonstrates a mixed financial performance. The company shows strength in solvency and profitability. However, liquidity, efficiency, and growth metrics are concerning. The company has low debt levels, indicating financial stability and reduced risk. Profitability ratios such as ROCE, ROE, and margins are strong, suggesting efficient operations and good earnings generation. Poor liquidity indicates potential difficulties in meeting short-term obligations. Inefficiency in asset utilization and a significant drop in revenue, operating profit, EPS, assets, and net income indicate the company is facing serious challenges. There is a moderate ability to cover interest and dividends. The company has poor EPS and book value per share, but manages capital expenditures reasonably well.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Overview
Ratio
Financial
Zenith Drugs Ltd Health Insights
Health Score : 4.63Health Score : 4.63

Zenith Drugs Ltd demonstrates a mixed financial performance. The company shows strength in solvency and profitability. However, liquidity, efficiency, and growth metrics are concerning. The company has low debt levels, indicating financial stability and reduced risk. Profitability ratios such as ROCE, ROE, and margins are strong, suggesting efficient operations and good earnings generation. Poor liquidity indicates potential difficulties in meeting short-term obligations. Inefficiency in asset utilization and a significant drop in revenue, operating profit, EPS, assets, and net income indicate the company is facing serious challenges. There is a moderate ability to cover interest and dividends. The company has poor EPS and book value per share, but manages capital expenditures reasonably well.

Latest Report

View All

The Latest Reports Are Not Available at the Moment. We’ll Notify You Once They’re Available.


Latest News

View All

The Latest News Is Not Available at the Moment. We’ll Notify You Once It’s Available.

Neutral

Overall Valuation Score

Highly Undervalued
Undervalued
Neutral
Overvalued
Highly Overvalued
Neutral

P/E RATIO (TTM)

18.28

Undervalued

Industry Median

28.62

Undervalued
Undervalued

Small Cap Median

27.17

Undervalued

P/E RATIO

7.52

P/B RATIO

1.16

Highly Undervalued

Industry Median

3.17

Highly Undervalued
Undervalued

Small Cap Median

2.62

Undervalued

P/S RATIO

0.52

Highly Undervalued

Industry Median

3.42

Highly Undervalued
Highly Undervalued

Small Cap Median

2.55

Highly Undervalued

Others

Neutral

PEG RATIO

0.00

Neutral
Highly Undervalued

EV/EBITDA RATIO

3.98

Highly Undervalued

The Calculations Shown Above Are Based on the Last Traded Price (LTP) of ₹42.05 as on Jun 21, 2026.

Markets Depth NSE

Buy Orders

  1. Bid

    Quantity

    Orders

  2. No buy depth

  3. Total

    0

    0

Sell Orders

  1. Ask

    Quantity

    Orders

  2. No sell depth

  3. Total

    0

    0

BidsOffers
50.00%50.00%

Markets Today NSE

  1. High

    0.00

  2. Low

    0.00

  3. Open

    0.00

  4. Close

    0.00

  5. Prev Close

    0.00

  6. Avg Price

    0.00

  7. Volume

    0

  8. Last Traded Quantity

    0

  9. Last Traded Time

    N/A

Price Movement Indicator

0.00

0.00
Today's Low

0.00
Today's High

Growth Ratio Summary
Growth Ratio SummaryGrowth Score : 2.00

The company's growth ratios are negative, indicating significant challenges. Declines in revenue, operating profit, EPS, assets, and net income suggest business contraction. This could reflect market challenges or internal operational issues. The negative growth rates raise concerns about the company's future prospects and sustainability. Focus needs to be on identifying the root causes of decline and implementing corrective strategies.

PoorRevenue Growth RatePoor
PoorOperating Profit Growth RatePoor
PoorEarnings Per Share (EPS) GrowthPoor
PoorAsset Growth RatePoor
PoorNet Income Growth RatePoor
Growth RatiosMar 2022Mar 2023Mar 2024
Revenue Growth Rate23.9114.91
Operating Profit Growth Rate28.5788.89
Earnings Per Share (EPS) Growth
Asset Growth Rate42.0337.76
Net Income Growth Rate66.67100
01.

Revenue Growth Rate

02.

Operating Profit Growth Rate

03.

Earnings Per Share (EPS) Growth

04.

Asset Growth Rate

05.

Net Income Growth Rate

Financial Ratio Summary
Financial Ratio SummaryFinancial Score : 4.20

The company's financial ratios present a mixed view. While capital expenditures are managed reasonably well, the adjusted and cash EPS are low. The book value and dividend per share are also poor. The company needs to improve its earnings and shareholder value.

WeakAdjusted Earnings Per Share (Adjusted EPS)Weak
WeakCash Earnings Per Share (Cash EPS)Weak
PoorBook Value Per SharePoor
PoorDividend Per Share (DPS)Poor
GoodCapital Expenditures (CapEx)Good
Financial RatiosMar 2022Mar 2023Mar 2024
Adjusted Earnings Per Share (Adjusted EPS)751256.47
Cash Earnings Per Share (Cash EPS)1001506.47
Book Value Per Share31043536.47
Dividend Per Share (DPS)0.5
Capital Expenditures (CapEx)2.65.65.3
01.

Adjusted Earnings Per Share (Adjusted EPS)

02.

Cash Earnings Per Share (Cash EPS)

03.

Book Value Per Share

04.

Dividend Per Share (DPS)

05.

Capital Expenditures (CapEx)

Profitability Ratio Summary
Profitability Ratio SummaryProfitability Score : 9.60

The company's profitability ratios are strong. High gross profit, ROCE, ROE, operating margin, and net margin indicate efficiency in operations and good earnings generation. The return on assets is reasonably good. The company is generating profits from its assets and equity.

ExcellentGross Profit MarginExcellent
ExcellentReturn on Capital Employed (ROCE)Excellent
ExcellentReturn on Equity (ROE)Excellent
AverageReturn on Assets (ROA)Average
ExcellentOperating MarginExcellent
ExcellentNet MarginExcellent
Profitability RatiosMar 2022Mar 2023Mar 2024
Gross Profit Margin6.527.0212.21
Return on Capital Employed (ROCE)27.32427
Return on Equity (ROE)24.1928.7416.13
Return on Assets (ROA)10.149.1812.59
Operating Margin7.617.8912.98
Net Margin3.264.397.63
01.

Gross Profit Margin

02.

Return on Capital Employed (ROCE)

03.

Return on Equity (ROE)

04.

Return on Assets (ROA)

05.

Operating Margin

06.

Net Margin

Efficiency Ratio Summary
Efficiency Ratio SummaryEfficiency Score : 3.33

The company's efficiency ratios present a mixed picture. While the days sales in inventory is relatively reasonable, indicating effective inventory management, the fixed asset, inventory, and capital turnover ratios are low, suggesting inefficient asset utilization. The high receivable days indicate challenges in collecting payments. There is potential for improvement in converting assets into revenue and managing receivables.

WeakFixed Asset Turnover RatioWeak
PoorInventory Turnover RatioPoor
PoorReceivables Turnover RatioPoor
GoodDays Sales in Inventory RatioGood
PoorReceivable DaysPoor
PoorCapital Turnover RatioPoor
Efficiency RatiosMar 2022Mar 2023Mar 2024
Fixed Asset Turnover Ratio9.29.511.91
Inventory Turnover Ratio7.175.834.6
Receivables Turnover Ratio2.852.812.26
Days Sales in Inventory Ratio50.9162.6179.35
Receivable Days128129.89161.5
Capital Turnover Ratio4.194.431.86
01.

Fixed Asset Turnover Ratio

02.

Inventory Turnover Ratio

03.

Receivables Turnover Ratio

04.

Days Sales in Inventory Ratio

05.

Receivable Days

06.

Capital Turnover Ratio

Coverage Ratio Summary
Coverage Ratio SummaryCoverage Score : 6.00

The company's coverage ratios show a moderate ability to meet its interest and dividend obligations. The interest coverage ratio indicates that the company can cover its interest expenses. The equity dividend coverage ratio suggests an ability to cover dividend payments. The company is meeting its obligations.

AverageInterest Coverage RatioAverage
AverageEquity Dividend Coverage RatioAverage
Coverage RatiosMar 2022Mar 2023Mar 2024
Interest Coverage Ratio34.55.33
Equity Dividend Coverage Ratio11.11
01.

Interest Coverage Ratio

02.

Equity Dividend Coverage Ratio

Solvency Ratio Summary
Solvency Ratio SummarySolvency Score : 9.00

The company exhibits strong solvency. Low debt and debt-to-equity ratios suggest minimal financial risk and a strong equity base. A high equity ratio further confirms financial stability. This allows the company greater flexibility in funding future growth and weathering economic downturns. The company's asset base is not overly burdened by debt, contributing to long-term sustainability.

ExcellentDebt RatioExcellent
ExcellentDebt to Equity RatioExcellent
AverageEquity RatioAverage
ExcellentDebt To Asset RatioExcellent
Solvency RatiosMar 2022Mar 2023Mar 2024
Debt Ratio0.440.320.12
Debt to Equity Ratio0.790.470.14
Equity Ratio0.560.680.88
Debt To Asset Ratio0.140.090.06
01.

Debt Ratio

02.

Debt to Equity Ratio

03.

Equity Ratio

04.

Debt To Asset Ratio

Liquidity Ratio Summary
Liquidity Ratio SummaryLiquidity Score : 2.68

The company's liquidity position raises concerns. The current and cash ratios are particularly weak, indicating a struggle to meet short-term obligations using liquid assets. While the quick ratio offers a slightly better outlook, the negative operating cash flow ratio suggests operational inefficiencies. Limited liquid assets may restrict flexibility in handling unforeseen expenses or investment opportunities.

PoorCurrent RatioPoor
WeakQuick RatioWeak
PoorCash RatioPoor
PoorOperating Cash Flow RatioPoor
Liquidity RatiosMar 2022Mar 2023Mar 2024
Current Ratio1.161.21.87
Quick Ratio0.910.861.47
Cash Ratio0.0600.14
Operating Cash Flow Ratio0.11-0.07-0.2
01.

Current Ratio

02.

Quick Ratio

03.

Cash Ratio

04.

Operating Cash Flow Ratio

Peer Comparison With 10 Companies

Peer Comparison empowers investors to evaluate a company against its industry peers using key financial metrics like P/E ratio, EPS, and profit margins. It helps identify whether a company is overvalued, undervalued, or performing in line with competitors. Investors can use this data to spot opportunities, assess risks, and make informed decisions. This contextual view adds depth beyond standalone company analysis.

NO Company Name Health Score P/E Ratio Valuation OPM EPS Latest Profit & Loss
1Par Drugs & Chemicals Ltd7.408.88Undervalued17.0010.6513.00
2Vaishali Pharma Ltd6.74103.62Overvalued4.000.314.00
3Mono Pharmacare Ltd6.166.26Neutral8.001.753.00
4JFL Life Sciences Ltd6.079.43Neutral12.001.946.00
5Quest Laboratories Ltd5.2711.21Neutral18.009.1615.00
6Sotac Pharmaceuticals Ltd5.2721.26Neutral18.004.456.00
7Zenith Drugs Ltd4.637.52Neutral17.002.3010.00
8Mangalam Drugs and Organics Ltd4.50-1.07Neutral-15.00-27.68-44.00
9Lasa Supergenerics Ltd4.39-2.61Highly Undervalued-7.00-6.80-34.00
10Krebs Biochemicals & Industries Ltd4.16-5.27Highly Undervalued-4.00-12.49-4.00
Management Assessment Summary
OrangeBalanced Management

Zenith Drugs' management shows promise with strong sales and profit growth, alongside improvements in operational efficiency. The company benefits from a substantial promoter holding. However, there are areas of concern, particularly regarding working capital management. Increasing debtor and inventory days, coupled with a shift in the cash conversion cycle, indicate operational inefficiencies. These factors suggest a mixed performance, where strengths in profitability are counterbalanced by challenges in managing working capital effectively.

Category Metric Value Assessment
PROS Profit Growth TTM: 115% Showing very strong growth
OPM Improvement Mar 2022: 8% to Mar 2024: 13% Demonstrating improving operational efficiency
Promoter Holding 69.98% Indicating confidence and alignment with shareholders
CONS Increasing Debtor Days Mar 2022: 128 to Mar 2024: 188 Suggesting potential issues with credit management
Increasing Inventory Days Mar 2022: 96 to Mar 2024: 249 Indicating potential challenges in inventory turnover
GoodFinancial Performance & GrowthGood
ExcellentCapital Efficiency & ReturnsExcellent
AverageFinancial Health & PrudenceAverage
WeakStrategic & Operational IndicatorsWeak
01.

Financial Performance & Growth

02.

Capital Efficiency & Returns

03.

Financial Health & Prudence

04.

Strategic & Operational Indicators

Risk Assessment Summary
OrangeBalanced Risk

The risk assessment for Zenith Drugs indicates a moderate level of risk. Strengths in profitability and returns are present, but concerns exist regarding working capital management. The increasing debtor days and inventory days suggest potential liquidity issues and operational inefficiencies.

AverageOff-balance sheet exposure quantificationAverage
AverageContingent liability evaluationAverage
GoodAccounting quality red flagsGood
01.

Off-balance sheet exposure quantification

02.

Contingent liability evaluation

03.

Accounting quality red flags

0 Credits RemainingUnlock Deep Technical Insights in Seconds Only with Dhanarthi AI

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 1 Hour Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1041.63Bullish
  3. SMA 2041.48Bullish
  4. SMA 5042.16Bullish
  5. EMA 1041.60Bullish
  6. EMA 2041.74Bullish
  7. EMA 5042.00Bullish
  8. DEMA 1041.51Bullish
  9. DEMA 2041.48Bullish
  10. DEMA 5041.79Bullish
  11. TEMA 1041.60Bullish
  12. TEMA 2041.42Bullish
  13. TEMA 5041.50Bullish
  14. MACD-0.19Bullish
  15. ADX14.45Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI54.74Neutral
  3. CCI65.07Neutral
  4. ROC 90.83Bullish
  5. ROC 144.94Bullish
  6. ROC 25-3.19Bearish
  7. Stoch K40.51Neutral
  8. Stoch D23.68Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper43.23Neutral
  3. BB Middle41.48Neutral
  4. BB Lower39.73Neutral
  5. ATR0.59High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI50.55Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 2 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1041.70Bullish
  3. SMA 2042.13Bullish
  4. SMA 5042.10Bullish
  5. EMA 1041.84Bullish
  6. EMA 2041.95Bullish
  7. EMA 5042.05Bullish
  8. DEMA 1041.77Bullish
  9. DEMA 2041.76Bullish
  10. DEMA 5042.12Bullish
  11. TEMA 1041.85Bullish
  12. TEMA 2041.69Bullish
  13. TEMA 5041.90Bullish
  14. MACD-0.14Bullish
  15. ADX15.12Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI52.26Neutral
  3. CCI2.63Neutral
  4. ROC 94.94Bullish
  5. ROC 14-0.58Bearish
  6. ROC 25-1.05Bearish
  7. Stoch K38.62Neutral
  8. Stoch D33.97Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper44.48Neutral
  3. BB Middle42.13Neutral
  4. BB Lower39.78Neutral
  5. ATR0.91High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI41.86Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Market Sentiment

Analysis Driven By 26 Technical Indicators From The 4 Hours Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Strong Bullish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 1042.23Bullish
  3. SMA 2042.16Bullish
  4. SMA 5041.71Bullish
  5. EMA 1042.06Bullish
  6. EMA 2042.17Bullish
  7. EMA 5041.97Bullish
  8. DEMA 1041.87Bullish
  9. DEMA 2042.12Bullish
  10. DEMA 5042.37Bullish
  11. TEMA 1041.82Bullish
  12. TEMA 2041.87Bullish
  13. TEMA 50N/AN/A
  14. MACD-0.07Bearish
  15. ADX12.38Weak Trend
Momentum Indicators (7)
  1. IndicatorValueSignal
  2. RSI51.00Neutral
  3. CCI-16.42Neutral
  4. ROC 9-3.19Bearish
  5. ROC 142.91Bullish
  6. ROC 25-4.39Bearish
  7. Stoch K38.96Neutral
  8. Stoch D49.21Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper44.41Neutral
  3. BB Middle42.16Neutral
  4. BB Lower39.90Neutral
  5. ATR1.65High Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI61.33Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Market Sentiment

Analysis Driven By 33 Technical Indicators From The 1 Day Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (22)
  1. IndicatorValueSignal
  2. SMA 1042.38Bearish
  3. SMA 2042.53Bearish
  4. SMA 5042.03Bullish
  5. SMA 10043.75Bearish
  6. SMA 20051.50Bearish
  7. EMA 1042.15Bearish
  8. EMA 2042.11Bearish
  9. EMA 5042.39Bearish
  10. EMA 10044.72Bearish
  11. EMA 20050.87Bearish
  12. DEMA 1042.08Bearish
  13. DEMA 2042.25Bearish
  14. DEMA 5041.04Bullish
  15. DEMA 10038.89Bullish
  16. DEMA 20038.90Bullish
  17. TEMA 1041.90Bullish
  18. TEMA 2042.32Bearish
  19. TEMA 5042.34Bearish
  20. TEMA 10040.28Bullish
  21. TEMA 200N/AN/A
  22. MACD0.08Bearish
  23. ADX11.61Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI49.92Neutral
  3. CCI-32.81Neutral
  4. ROC 14-3.56Bearish
  5. ROC 252.56Bullish
  6. Stoch K45.97Neutral
  7. Stoch D37.31Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper46.82Neutral
  3. BB Middle42.53Neutral
  4. BB Lower38.23Neutral
  5. ATR2.35Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI48.42Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 21 Technical Indicators From The 1 Week Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bearish

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (10)
  1. IndicatorValueSignal
  2. SMA 2043.51Bullish
  3. SMA 5054.45Bearish
  4. EMA 2044.63Bearish
  5. EMA 5053.11Bearish
  6. DEMA 2039.59Bullish
  7. DEMA 5039.89Bullish
  8. TEMA 2041.10Bullish
  9. TEMA 50N/AN/A
  10. MACD-3.41Bullish
  11. ADX14.96Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSI44.13Neutral
  3. CCI-80.35Neutral
  4. ROC 14-2.88Bearish
  5. ROC 25-13.58Bearish
  6. Stoch K64.05Neutral
  7. Stoch D55.14Neutral
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper50.73Neutral
  3. BB Middle43.51Neutral
  4. BB Lower36.28Neutral
  5. ATR5.92Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI35.86Neutral

Overall Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Market Sentiment

Analysis Driven By 25 Technical Indicators From The 1 Month Timeframe

Trend Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Momentum Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Volatility Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Bullish

Volume Score

Strong Bearish

Bearish

Neutral

Bullish

Strong Bullish

Neutral

Trend Indicators (14)
  1. IndicatorValueSignal
  2. SMA 646.27Bullish
  3. SMA 1255.91Bearish
  4. SMA 2471.62Bearish
  5. EMA 647.51Bullish
  6. EMA 1254.54Bearish
  7. EMA 2466.95Bearish
  8. DEMA 641.54Bullish
  9. DEMA 1242.26Bullish
  10. DEMA 24N/AN/A
  11. TEMA 642.54Bullish
  12. TEMA 12N/AN/A
  13. TEMA 24N/AN/A
  14. MACDN/AN/A
  15. ADX8.51Weak Trend
Momentum Indicators (6)
  1. IndicatorValueSignal
  2. RSIN/AN/A
  3. CCIN/AN/A
  4. ROC 25-25.20Bearish
  5. ROC 50N/AN/A
  6. Stoch KN/AN/A
  7. Stoch DN/AN/A
Volatility Indicators (4)
  1. IndicatorValueSignal
  2. BB Upper99.67Neutral
  3. BB Middle66.10Neutral
  4. BB Lower32.53Neutral
  5. ATR18.70Low Volatility
Volume Indicators (1)
  1. IndicatorValueSignal
  2. MFI42.96Neutral